← Explore

Ultrasound Stimulation Modulates Microglia M1/M2 Polarization and Affects Hippocampal Proteomic Changes in a Mouse Model of Alzheimer's Disease

Xinliang Lu, Wenxian Sun, Li Leng, Yuting Yang, Shuting Gong, Qi Zou, Haijun Niu, Cuibai Wei

Immunity, Inflammation and Disease 2024, 12 · 10.1002/iid3.70061

rodentalzheimers diseasehistology molecular

Abstract

Background The effectiveness of ultrasound stimulation in treating Alzheimer's disease (AD) has been reported in previous studies, but the underlying mechanisms remain unclear. This study investigated the effects of ultrasound stimulation on the proportion and function of microglia of different phenotypes, as well as on the levels of inflammatory factors. Additionally, it revealed the alterations in proteomic molecules in the mouse hippocampus following ultrasound stimulation treatment, aiming to uncover potential new molecular mechanisms. Methods Ultrasound stimulation was used to stimulate the hippocampus for 30 min per day for 5 days in the ultrasound stimulation-treated group. Amyloid plaque deposition was measured using immunofluorescence staining. M1 and M2 type microglia were labeled using immunofluorescent double staining, and the ratio was calculated. The levels of Aβ42, IL-10, and TNF-α were determined using ELISA kits. The quantitative proteomics method was employed to explore molecular changes in hippocampal proteins. Results Ultrasound stimulation treatment reduced the average fluorescence intensity of amyloid plaques and the concentration of Aβ42. Compared to the AD group, ultrasound stimulation resulted in a 14% reduction in the proportion of M1 microglia and a 12% increase in the proportion of M2 microglia. The concentration of the anti-inflammatory factor IL-10 was significantly increased in the ultrasound stimulation-treated group. Proteomics analysis revealed 753 differentially expressed proteins between the ultrasound stimulation-treated and AD groups, with most being enriched in the oxidative phosphorylation pathway of mitochondria. Additionally, the activity of cytochrome c oxidase, involved in oxidative phosphorylation, was increased after ultrasound stimulation treatment. Conclusions Ultrasound stimulation affects microglial polarization, reduces amyloid plaque load, and enhances levels of anti-inflammatory factors in APP/PS1 mice. Proteomics analysis reveals molecular changes in hippocampal proteins after ultrasound stimulation treatment. The mechanism behind ultrasound stimulation-induced modulation of microglial polarization may be related to changes in mitochondrial oxidative phosphorylation.

Abstract via europepmc.

Speciesmouse (APP/PS1; C57BL/6)
Subjects11 animals
Sessions per subject5
Randomisedyes
Blindingnot reported
Sham / controlinactive transducer
Auditory controlnot reported
Readout timingoffline
Anaesthesiaanaesthetised
Readoutshistology molecularImmunofluorescence staining for amyloid plaques and Iba1/CD86 (M1) and Iba1/CD206 (M2) microglial markers; ELISA for Aβ42, IL-10, TNF-α; TMT-based quantitative proteomics; Complex IV (cytochrome c oxidase) activity assay
Direction of effectnot assessedStudy did not assess excitatory/inhibitory neural effects; ultrasound stimulation shifted microglial polarization from M1 to M2, reduced amyloid plaque load and Aβ42, and increased anti-inflammatory IL-10.
Adverse eventsnot reported

Exposures

Exposure 1: Hippocampal ultrasound stimulation in APP/PS1 mice

Target: hippocampus — “hippocampus
Device: Olympus / Panametrics · Olympus · V303-SU

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)1,000✓✓
Pulse duration (ms)not reportedimplied by duty cycle ÷ PRF: 2.5 ms (not stated by the paper)
Pulse repetition frequency (Hz)40✓✓
Duty cycle (%)10✓✓
Sonication duration (s)5✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Ispta, domain unspecified (W/cm²)0.294✓✓
Protocol, in the paper’s words

The excitation voltage was set at 330 mVpp, and Ispta was calculated to be 294 mW/cm² based on measured sound pressure. The PRF was set to 40 Hz. The remaining parameters were set as follows: DC = 10%, SD = 5 s, ISI = 5 s. The ultrasonic probe was targeted at the hippocampus (1.8 mm posterior, 1 mm lateral to Bregma) for 30 min per day (15 min on the left and 15 min on the right side) for 5 days.

Flags from extraction

  • exposures[0].timing.pulse_duration_msPaper gives duty cycle (10%) and PRF (40 Hz) but never states pulse duration directly; not computed per instructions.
  • n_subjectsOnly the ultrasound-exposed (US) group is counted; NC and AD sham groups (n=11 each) received no active ultrasound.
  • unspecified_domain.ispta_w_cm2Paper does not state whether the 294 mW/cm2 Ispta value is a free-field or in-situ measurement.
  • adverse_eventsPaper notes mice that died mid-experiment from surgical complications were excluded, but does not explicitly assess ultrasound-related adverse events.